Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).
about
Cancer stem cell metabolism: a potential target for cancer therapyRole of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patientsThe role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cellsErlotinib antagonizes ABC transporters in acute myeloid leukemia.Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicinPharmacogenomics in acute myeloid leukemia.Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy.Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.Can the assessment of ABCB1 gene expression predict its function in vitro?"Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183".P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells.Therapeutics formulated to target cancer stem cells: Is it in our future?Apoptosis Induced by the Curcumin Analogue EF-24 Is Neither Mediated by Oxidative Stress-Related Mechanisms nor Affected by Expression of Main Drug Transporters ABCB1 and ABCG2 in Human Leukemia Cells.ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
P2860
Q28079045-2B28C849-1B32-4584-A426-F4C01E11D097Q30274798-4F21B736-4E54-43D7-A22E-3D0130302319Q33472987-06DE8AD7-6266-4AC9-862E-224D9A222D9CQ33737469-9383CC73-D90A-42C1-B966-7B66C3D7ED78Q34166391-89421DD8-CE1B-4B84-9CF1-17A666805715Q36426524-0DA349E5-F554-4F3C-AE6C-9CA1977474FEQ36932014-2D878059-80D5-46CE-BB18-749A3FC2070BQ37627876-92E93D87-8D1B-4459-9B71-AE2F3E5C4923Q38140118-43FB9B4D-CA78-4EBE-B888-EDAC24EC2144Q38618124-13A6C9D6-1D84-485F-8F74-A5BCC89A20C1Q38947143-1D961B0A-184D-4058-BD17-D96D916A2514Q38970000-CFD2D5F9-B4EC-479A-A1C0-43892A904A0AQ39552900-8FC351AF-5C3D-4D20-986C-FAAD4414AB6BQ39609017-E0A489F2-8136-49EC-9C58-3D079E1EB80AQ39767667-FE12D28E-C23D-4B6E-A5C5-810CC878EC38Q46271548-D9229982-FDE0-460D-B104-972295DB2ADCQ58798114-6A37A040-EC9F-41BF-B20E-7E2FD31F798D
P2860
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@ast
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@en
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia
@nl
type
label
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@ast
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@en
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia
@nl
prefLabel
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@ast
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@en
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia
@nl
P2093
P2860
P356
P1433
P1476
Zosuquidar restores drug sensi ...... acute myeloid leukemia (AML).
@en
P2093
Anne-Marie Faussat
Hamid Morjani
Jean-Pierre Marie
Jean-Yves Perrot
Ollivier Legrand
Ruoping Tang
Simy Cohen
Thomas Storme
Zora Marjanovic
P2860
P2888
P356
10.1186/1471-2407-8-51
P407
P577
2008-02-13T00:00:00Z
P5875
P6179
1037051589